EP Patent

EP1351686A2 — Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade

Assigned to Pharmacia LLC · Expires 2003-10-15 · 23y expired

What this patent protects

The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation ca…

USPTO Abstract

The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.

Drugs covered by this patent

Patent Metadata

Patent number
EP1351686A2
Jurisdiction
EP
Classification
—
Expires
2003-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacia LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.